Form 4 for OFIX Orthofix Medical Inc.

Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-05 · accession 0001209191-24-001272 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-01-09	2024-01-08	OFIX	Gillespie Geoffrey C	VP, Ctrl, Interim CFO	A - Grant	$13.29	+4,703	37.4K	+14%	+$62.5K
D	2024-01-09	2024-01-05	OFIX	Gillespie Geoffrey C	VP, Ctrl, Interim CFO	F - Tax	$12.67	-459	32.7K	-1%	-$5,816
D	2024-01-09	2024-01-08	OFIX	Gillespie Geoffrey C	VP, Ctrl, Interim CFO	A - Grant	$0.00	+11.0K	11.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-08	A	A	4,703	$13.29	37,385	D	—	—	(F2) The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. (F1) Includes 31,423 previously reported unvested restricted stock units.
2	Common	Common Stock	2024-01-05	F	D	459	$12.67	32,682	D	—	—	(F1) Includes 31,423 previously reported unvested restricted stock units.
3	Derivative	Employee Stock Option (Right to Buy)	2024-01-08	A	A	10,967	$0.00	10,967	D	$13.29 · — to 2031-01-08	10,967 Common Stock	(F3) The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.